Susquehanna International Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.64M | Buy |
484,823
+392,798
| +427% | +$5.38M | ﹤0.01% | 1045 |
|
|
2025
Q1 | $1.02M | Buy |
92,025
+51,892
| +129% | +$574K | ﹤0.01% | 3327 |
|
|
2024
Q4 | $427K | Buy |
40,133
+3,118
| +8% | +$33.2K | ﹤0.01% | 4291 |
|
|
2024
Q3 | $470K | Sell |
37,015
-59,330
| -62% | -$753K | ﹤0.01% | 3734 |
|
|
2024
Q2 | $1.62M | Buy |
96,345
+68,934
| +251% | +$1.16M | ﹤0.01% | 1980 |
|
|
2024
Q1 | $411K | Buy |
27,411
+683
| +3% | +$10.2K | ﹤0.01% | 3788 |
|
|
2023
Q4 | $401K | Buy |
26,728
+6,553
| +32% | +$98.3K | ﹤0.01% | 4149 |
|
|
2023
Q3 | $283K | Buy |
20,175
+7,441
| +58% | +$104K | ﹤0.01% | 4107 |
|
|
2023
Q2 | $132K | Sell |
12,734
-186,699
| -94% | -$1.93M | ﹤0.01% | 4874 |
|
|
2023
Q1 | $1.84M | Buy |
199,433
+160,461
| +412% | +$1.48M | ﹤0.01% | 2059 |
|
|
2022
Q4 | $346K | Buy |
+38,972
| New | +$346K | ﹤0.01% | 3713 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6920 |
|
|
2021
Q2 | – | Sell |
-14,580
| Closed | -$284K | – | 5943 |
|
|
2021
Q1 | $284K | Sell |
14,580
-566
| -4% | -$11K | ﹤0.01% | 4417 |
|
|
2020
Q4 | $273K | Sell |
15,146
-23,150
| -60% | -$417K | ﹤0.01% | 3989 |
|
|
2020
Q3 | $739K | Sell |
38,296
-48,411
| -56% | -$934K | ﹤0.01% | 2609 |
|
|
2020
Q2 | $2.27M | Sell |
86,707
-6,403
| -7% | -$167K | ﹤0.01% | 1366 |
|
|
2020
Q1 | $1.66M | Sell |
93,110
-9,335
| -9% | -$167K | ﹤0.01% | 1477 |
|
|
2019
Q4 | $3.42M | Buy |
102,445
+47,916
| +88% | +$1.6M | ﹤0.01% | 1055 |
|
|
2019
Q3 | $1.3M | Buy |
54,529
+46,749
| +601% | +$1.11M | ﹤0.01% | 1729 |
|
|
2019
Q2 | $280K | Buy |
+7,780
| New | +$280K | ﹤0.01% | 3548 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4555 |
|
|
2018
Q4 | – | Sell |
-5,141
| Closed | -$243K | – | 4904 |
|
|
2018
Q3 | $243K | Buy |
+5,141
| New | +$243K | ﹤0.01% | 2609 |
|